Literature DB >> 16213790

The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.

Elly M Hol1, Fred W van Leeuwen, David F Fischer.   

Abstract

Ubiquitin-containing cellular inclusions are characteristic of major neurodegenerative diseases and suggest an involvement of the ubiquitin-proteasome system. The frameshifted form of ubiquitin has proved to be a valuable tool for studying the role of the ubiquitin-proteasome system. It is an endogenous reporter for proteasome activity in human pathology but it is also capable of inhibiting proteasomal degradation. Current studies have revealed that the frameshifted form of ubiquitin accumulates in the brains of patients with Alzheimer's disease but not in those with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213790     DOI: 10.1016/j.molmed.2005.09.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  18 in total

1.  Amyloid β-induced FOXRED2 mediates neuronal cell death via inhibition of proteasome activity.

Authors:  SangMi Shim; WonJae Lee; HaeWon Chung; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2010-10-23       Impact factor: 9.261

Review 2.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

3.  Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration.

Authors:  Z Tan; X Sun; F-S Hou; H-W Oh; L G W Hilgenberg; E M Hol; F W van Leeuwen; M A Smith; D K O'Dowd; S S Schreiber
Journal:  Cell Death Differ       Date:  2007-06-15       Impact factor: 15.828

Review 4.  Protein quality control in neurodegeneration: walking the tight rope between health and disease.

Authors:  E M Hol; W Scheper
Journal:  J Mol Neurosci       Date:  2007-03-24       Impact factor: 3.444

5.  The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair.

Authors:  Emmette R Hutchison; Eitan Okun; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

6.  Conformational equilibria of bulged sites in duplex DNA studied by EPR spectroscopy.

Authors:  Alyssa L Smith; Pavol Cekan; Greg P Brewood; Tamara M Okonogi; Saba Alemayehu; Eric J Hustedt; Albert S Benight; Snorri Th Sigurdsson; Bruce H Robinson
Journal:  J Phys Chem B       Date:  2009-03-05       Impact factor: 2.991

7.  Expansion of the mycobacterial "PUPylome".

Authors:  Jeramie Watrous; Kristin Burns; Wei-Ting Liu; Anand Patel; Vivian Hook; Vineet Bafna; Clifton E Barry; Steve Bark; Pieter C Dorrestein
Journal:  Mol Biosyst       Date:  2009-11-16

Review 8.  The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.

Authors:  S W French; A S Mendoza; Y Peng
Journal:  Exp Mol Pathol       Date:  2016-04-09       Impact factor: 3.362

9.  Mutant ubiquitin-mediated beta-secretase stability via activation of caspase-3 is related to beta-amyloid accumulation in ischemic striatum in rats.

Authors:  Yong Zhang; Man Xiong; Ri-Qiang Yan; Feng-Yan Sun
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-21       Impact factor: 6.200

10.  Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.

Authors:  Elizabeth M H Tank; Heather L True
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.